{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:08:17Z","timestamp":1772694497735,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA056438"],"award-info":[{"award-number":["R01DA056438"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>U.S. young adults account for a disproportionate share of new HIV diagnoses. Despite this, no national study has examined recent trends in HIV pre-exposure prophylaxis (PrEP) dispensing to this age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess trends in PrEP dispensing to young adults from 2016 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross sectional study of the IQVIA Longitudinal Prescription Database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Young adults aged 18\u201325\u00a0years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measures<\/jats:title>\n                    <jats:p>Quarterly PrEP dispensing rate (number of young adults with dispensed PrEP prescriptions per 100,000 U.S. young adults), quarterly PrEP initiation rate (number of young adults with a new dispensed PrEP prescription per 100,000 U.S. young adults), and quarterly mean PrEP persistence (number of days with an active PrEP prescription in the 180\u00a0days after the new PrEP prescription ended among those initiating therapy). Joinpoint regression was used to identify slope changes and calculate the quarterly percent change (QPC). Subgroup analyses were conducted by age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>Analyses included 1,450,296 PrEP prescriptions dispensed between January 1, 2016-December 31, 2023 to 239,780 young adults. The quarterly PrEP dispensing rate increased sharply between 2016\u20132018, from 26.4 to 100.7 prescriptions per 100,000 people (QPC: 12.5%, 95% CI: 10.0 to 15.1). Afterwards, this rate increased gradually to 208.4 prescriptions per 100,000 people in 2023 (QPC: 3.5%, 95% CI: 2.7 to 4.3). Trends in the quarterly PrEP initiation rate were qualitatively similar. From 2016 to 2023, quarterly mean persistence decreased from 111.6 to 98.4\u00a0days (QPC: -0.4%, 95% CI: -0.6, -0.2). Compared with patients aged 22\u201325\u00a0years, those aged 18\u201321\u00a0years had lower quarterly PrEP dispensing and initiation rates throughout 2016\u20132023. Persistence was lower in these younger patients in 2016, but the gap narrowed over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dispensing and initiation of PrEP among young adults is increasing, but treatment episodes are shortening. Efforts to promote retention in therapy are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-09574-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:43:45Z","timestamp":1746791025000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["National Trends in HIV Pre-Exposure Prophylaxis Dispensing to Young Adults, 2016\u20132023"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8495-9530","authenticated-orcid":false,"given":"Nina E.","family":"Hill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kao-Ping","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"9574_CR1","unstructured":"CDC. Pre-Exposure Prophylaxis (PrEP) | HIV Risk and Prevention | HIV\/AIDS | CDC. March 8, 2023. https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html. Accessed 30 August 2024."},{"key":"9574_CR2","unstructured":"US Public Health Service: PREEXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE UNITED STATES \u2013 2021 UPDATE, A CLINICAL PRACTICE GUIDELINE. Published online 2021."},{"key":"9574_CR3","unstructured":"Dear Colleague: Preliminary Data on Pre-Exposure Prophylaxis Coverage Released | Policy, Planning, and Strategic Communication | HIV | CDC. October 18, 2023. https:\/\/www.cdc.gov\/hiv\/policies\/dear-colleague\/dcl\/20231017.html. Accessed 30 August 2024."},{"issue":"3","key":"9574_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/cid\/ciz894","volume":"71","author":"DP Serota","year":"2020","unstructured":"Serota DP, Rosenberg ES, Sullivan PS, et al. Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study. Clin Infect Dis. 2020;71(3):574-582. https:\/\/doi.org\/10.1093\/cid\/ciz894.","journal-title":"Clin Infect Dis."},{"key":"9574_CR5","unstructured":"AIDSVu Releases New Data Showing Significant Inequities in PrEP Use Among Black and Hispanic Americans. AIDSVu. July 29, 2022. https:\/\/aidsvu.org\/prep-use-race-ethnicity-launch-22\/. Accessed 13 November 2024."},{"key":"9574_CR6","unstructured":"CDC. Fast Facts: HIV in the US by Age. HIV. June 26, 2024. https:\/\/www.cdc.gov\/hiv\/data-research\/facts-stats\/age.html. Accessed 30 August 2024."},{"key":"9574_CR7","doi-asserted-by":"publisher","unstructured":"Ocfemia MCB. HIV diagnoses among persons aged 13\u201329 years \u2014 United States, 2010\u20132014. MMWR Morb Mortal Wkly Rep. 2018;67. https:\/\/doi.org\/10.15585\/mmwr.mm6707a2.","DOI":"10.15585\/mmwr.mm6707a2"},{"key":"9574_CR8","unstructured":"HIV and Adolescents and Young Adults | NIH. https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/hiv-and-adolescents-and-young-adults. Accessed 14 March 2025."},{"issue":"5","key":"9574_CR9","doi-asserted-by":"publisher","first-page":"e2023062599","DOI":"10.1542\/peds.2023-062599","volume":"152","author":"AA Kimball","year":"2023","unstructured":"Kimball AA, Zhu W, Leonard J, et al. HIV preexposure prophylaxis provision among adolescents: 2018 to 2021. Pediatrics. 2023;152(5):e2023062599. https:\/\/doi.org\/10.1542\/peds.2023-062599.","journal-title":"Pediatrics."},{"key":"9574_CR10","doi-asserted-by":"publisher","unstructured":"Mann LM, Zhu W, Huang YLA, Kourtis AP, Fanfair RN, Hoover KW. Trends in oral and injectable HIV\u00a0preexposure prophylaxis prescriptions in the US, 2013\u20132023. JAMA. 2024. https:\/\/doi.org\/10.1001\/jama.2024.21493.","DOI":"10.1001\/jama.2024.21493"},{"issue":"3","key":"9574_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/cid\/ciaa037","volume":"72","author":"YLA Huang","year":"2021","unstructured":"Huang YLA, Tao G, Smith DK, Hoover KW. Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012\u20132017. Clin Infect Dis. 2021;72(3):379-385. https:\/\/doi.org\/10.1093\/cid\/ciaa037.","journal-title":"Clin Infect Dis."},{"issue":"7624","key":"9574_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD.","journal-title":"BMJ."},{"issue":"2","key":"9574_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/ciw701","volume":"64","author":"H Wu","year":"2017","unstructured":"Wu H, Mendoza MCB, Huang YLA, Hayes T, Smith DK, Hoover KW. Uptake of HIV preexposure prophylaxis among commercially insured persons\u2014United States, 2010\u20132014. Clin Infect Dis. 2017;64(2):144-149. https:\/\/doi.org\/10.1093\/cid\/ciw701.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"9574_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0033354920904085","volume":"135","author":"NW Furukawa","year":"2020","unstructured":"Furukawa NW, Smith DK, Gonzalez CJ, et al. Evaluation of algorithms used for PrEP surveillance using a reference population from New York City, July 2016\u2013June 2018. Public Health Rep. 2020;135(2):202-210. https:\/\/doi.org\/10.1177\/0033354920904085.","journal-title":"Public Health Rep."},{"key":"9574_CR15","unstructured":"National Cancer Institute. Joinpoint Regression Program. November 13, 2024. https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed 14 November 2024."},{"key":"9574_CR16","unstructured":"American young adults report having fewer sexual partners, higher rates of abstention | Institute for Social Research. https:\/\/isr.umich.edu\/news-events\/news-releases\/american-young-adults-report-having-fewer-sexual-partners-higher-rates-of-abstention\/. Accessed 26 November 2024."},{"key":"9574_CR17","unstructured":"CDC. Clinical Guidance for PrEP. HIV Nexus: CDC Resources for Clinicians. August 20, 2024. https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html. Accessed 26 November 2024."},{"key":"9574_CR18","unstructured":"Introduction: Access to Primary Care Is Worsening. Milbank Memorial Fund. https:\/\/www.milbank.org\/publications\/the-health-of-us-primary-care-2024-scorecard-report-no-one-can-see-you-now\/introduction-access-to-primary-care-is-worsening\/. Accessed 26 November 2024."},{"issue":"10","key":"9574_CR19","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamainternmed.2024.3998","volume":"184","author":"S Bakre","year":"2024","unstructured":"Bakre S, Chang HY, Doshi JA, et al. Clinician specialty and HIV PrEP prescription reversals and abandonments. JAMA Intern Med. 2024;184(10):1204-1211. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3998.","journal-title":"JAMA Intern Med."},{"issue":"2","key":"9574_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jadohealth.2018.03.016","volume":"63","author":"GD Hart-Cooper","year":"2018","unstructured":"Hart-Cooper GD, Allen I, Irwin CE, Scott H. Adolescent health providers\u2019 willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to youth at risk of HIV infection in the United States. J Adolesc Health Off Publ Soc Adolesc Med. 2018;63(2):242-244. https:\/\/doi.org\/10.1016\/j.jadohealth.2018.03.016.","journal-title":"J Adolesc Health Off Publ Soc Adolesc Med."},{"key":"9574_CR21","unstructured":"Rae M, Claxton G, Published AD. Dependent coverage for young adults in employer-sponsored health plans. KFF. October 21, 2024. https:\/\/www.kff.org\/private-insurance\/issue-brief\/dependent-coverage-for-young-adults-in-employer-sponsored-health-plans\/. Accessed 26 November 2024."},{"key":"9574_CR22","unstructured":"Copen CE, Dittus PJ, Leichliter JS. Confidentiality Concerns and Sexual and Reproductive Health Care Among Adolescents and Young Adults Aged 15-25. NCHS Data Brief. 2016;(266):1-8."},{"issue":"1","key":"9574_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jadohealth.2017.10.011","volume":"62","author":"L Fuentes","year":"2018","unstructured":"Fuentes L, Ingerick M, Jones R, Lindberg L. Adolescents\u2019 and young adults\u2019 reports of barriers to confidential health care and receipt of contraceptive services. J Adolesc Health Off Publ Soc Adolesc Med. 2018;62(1):36-43. https:\/\/doi.org\/10.1016\/j.jadohealth.2017.10.011.","journal-title":"J Adolesc Health Off Publ Soc Adolesc Med."},{"key":"9574_CR24","unstructured":"AIDSVu: Location Profile for the HIV Epidemic in the United States. Location Profile - AIDSVu. https:\/\/map.aidsvu.org\/profiles\/nation\/usa\/prevention-and-testing#1-2-PnR. Accessed 1 November 2024."},{"key":"9574_CR25","unstructured":"AIDSVu Releases New PrEP Data and Launches PrEPVu.org, A New PrEP Equity Platform. AIDSVu. June 25, 2024. https:\/\/aidsvu.org\/news-updates\/aidsvu-releases-new-prep-data-and-launches-prepvu-org-a-new-prep-equity-platform\/. Accessed 22 November 2024."},{"issue":"11","key":"9574_CR26","doi-asserted-by":"publisher","first-page":"e0259665","DOI":"10.1371\/journal.pone.0259665","volume":"16","author":"E Zang","year":"2021","unstructured":"Zang E, West J, Kim N, Pao C. U.S. regional differences in physical distancing: Evaluating racial and socioeconomic divides during the COVID-19 pandemic. PLoS ONE. 2021;16(11):e0259665. https:\/\/doi.org\/10.1371\/journal.pone.0259665.","journal-title":"PLoS ONE."},{"issue":"4","key":"9574_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","volume":"16","author":"PS Sullivan","year":"2019","unstructured":"Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation strategies to increase PrEP uptake in the South. Curr HIV\/AIDS Rep. 2019;16(4):259. https:\/\/doi.org\/10.1007\/s11904-019-00447-4.","journal-title":"Curr HIV\/AIDS Rep."},{"key":"9574_CR28","unstructured":"CDC\u2019s HIV Prevention Priorities | Mobilizing to End the Epidemic | Strategic Priorities | Policy and Law | HIV\/AIDS | CDC. May 14, 2024. https:\/\/www.cdc.gov\/hiv\/policies\/strategic-priorities\/mobilizing\/prevention-priorities.html. Accessed 26 November 2024."},{"key":"9574_CR29","unstructured":"Preventing HIV with Pharmacist-Prescribed PrEP. R Street Institute. https:\/\/www.rstreet.org\/research\/preventing-hiv-with-pharmacist-prescribed-prep\/. Accessed 6 March 2025."},{"key":"9574_CR30","unstructured":"McDermott D, Cox C, Rudowitz R, Published RG. How Has the Pandemic Affected Health Coverage in the U.S.? KFF. December 9, 2020. https:\/\/www.kff.org\/policy-watch\/how-has-the-pandemic-affected-health-coverage-in-the-u-s\/. Accessed 26 November 2024."},{"issue":"4","key":"9574_CR31","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s11606-020-05651-2","volume":"35","author":"P Saberi","year":"2020","unstructured":"Saberi P, Scott HM. On-demand oral pre-exposure prophylaxis with tenofovir\/emtricitabine: what every clinician needs to know. J Gen Intern Med. 2020;35(4):1285-1288. https:\/\/doi.org\/10.1007\/s11606-020-05651-2.","journal-title":"J Gen Intern Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09574-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09574-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09574-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:03:52Z","timestamp":1769691832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09574-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9574"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09574-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate Declarations:"}},{"value":"Dr. Chua reports consulting for the U.S. Department of Justice for unrelated work. The other authors declare no competing interests regarding the research reported in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}}]}}